Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Reexamination Certificate
2005-10-11
2005-10-11
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
C424S009400, C424S052000, C424S193100, C435S007100, C530S391300, C530S328000
Reexamination Certificate
active
06953567
ABSTRACT:
Thiol-containing peptides can be radiolabeled with fluorine-18 (F-18) by reacting a peptide comprising a free thiol group with an F-18-bound labelling reagent which also has a group that is reactive with thiols. The resulting F-18-labeled peptides may be targeted to a tissue of interest using bispecific antibodies or bispecific antibody fragments having one arm specific for the F-18-labeled peptide or a low molecular weight hapten conjugated to the F-18-labeled peptide, and another arm specific to the targeted tissue. The targeted tissue is subsequently visualized by clinical positron emission tomography.
REFERENCES:
Kuby et al, 1994, Immunology, Second edition, pp. 86-96.
Colman et al, 1994, A structural view of immune recognition by antibodies, pp. 33-36.
Chan Christina
Heller Ehrman LLP
Huynh Phuong
Immunomedics Inc.
LandOfFree
Fluorination of proteins and peptides for F-18 positron... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorination of proteins and peptides for F-18 positron..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorination of proteins and peptides for F-18 positron... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3471194